These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

557 related articles for article (PubMed ID: 29956629)

  • 1. Challenges and Opportunities from Basic Cancer Biology for Nanomedicine for Targeted Drug Delivery.
    Xie X; Zhang Y; Li F; Lv T; Li Z; Chen H; Jia L; Gao Y
    Curr Cancer Drug Targets; 2019; 19(4):257-276. PubMed ID: 29956629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent insights in nanotechnology-based drugs and formulations designed for effective anti-cancer therapy.
    Piktel E; Niemirowicz K; Wątek M; Wollny T; Deptuła P; Bucki R
    J Nanobiotechnology; 2016 May; 14(1):39. PubMed ID: 27229857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mesoporous Silica Nanoparticles as a Prospective and Promising Approach for Drug Delivery and Biomedical Applications.
    Pu X; Li J; Qiao P; Li M; Wang H; Zong L; Yuan Q; Duan S
    Curr Cancer Drug Targets; 2019; 19(4):285-295. PubMed ID: 30520373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Clinical Translation of Organic Nanomaterials for Cancer Therapy: A Focus on Polymeric Nanoparticles, Micelles, Liposomes and Exosomes.
    Palazzolo S; Bayda S; Hadla M; Caligiuri I; Corona G; Toffoli G; Rizzolio F
    Curr Med Chem; 2018; 25(34):4224-4268. PubMed ID: 28875844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanotechnology platforms and physiological challenges for cancer therapeutics.
    Kim KY
    Nanomedicine; 2007 Jun; 3(2):103-10. PubMed ID: 17442621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanomaterials for theranostics: recent advances and future challenges.
    Lim EK; Kim T; Paik S; Haam S; Huh YM; Lee K
    Chem Rev; 2015 Jan; 115(1):327-94. PubMed ID: 25423180
    [No Abstract]   [Full Text] [Related]  

  • 7. Nanomedicine targets iron metabolism for cancer therapy.
    Lin L; Chen H; Zhao R; Zhu M; Nie G
    Cancer Sci; 2022 Mar; 113(3):828-837. PubMed ID: 34962017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug Delivery in Cancer Therapy, Quo Vadis?
    Lu ZR; Qiao P
    Mol Pharm; 2018 Sep; 15(9):3603-3616. PubMed ID: 29553749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perspectives and advancements in the design of nanomaterials for targeted cancer theranostics.
    Tan YY; Yap PK; Xin Lim GL; Mehta M; Chan Y; Ng SW; Kapoor DN; Negi P; Anand K; Singh SK; Jha NK; Lim LC; Madheswaran T; Satija S; Gupta G; Dua K; Chellappan DK
    Chem Biol Interact; 2020 Sep; 329():109221. PubMed ID: 32768398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. "Combo" nanomedicine: Co-delivery of multi-modal therapeutics for efficient, targeted, and safe cancer therapy.
    Kemp JA; Shim MS; Heo CY; Kwon YJ
    Adv Drug Deliv Rev; 2016 Mar; 98():3-18. PubMed ID: 26546465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. To exploit the tumor microenvironment: Since the EPR effect fails in the clinic, what is the future of nanomedicine?
    Danhier F
    J Control Release; 2016 Dec; 244(Pt A):108-121. PubMed ID: 27871992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanomedicine to Deal With Cancer Cell Biology in Multi-Drug Resistance.
    Tekchandani P; Kurmi BD; Paliwal SR
    Mini Rev Med Chem; 2017; 17(18):1793-1810. PubMed ID: 26891930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanomedicine: Innovative Strategies and Recent Advances in Targeted Cancer Therapy.
    Gautam RK; Mittal P; Goyal R; Dua K; Mishra DK; Sharma S; Singla RK
    Curr Med Chem; 2024; 31(28):4479-4494. PubMed ID: 37828674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advancement in design of nanostructured lipid carriers for cancer targeting and theranostic application.
    Rizwanullah M; Ahmad MZ; Garg A; Ahmad J
    Biochim Biophys Acta Gen Subj; 2021 Sep; 1865(9):129936. PubMed ID: 34058266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulating glucose metabolism using nanomedicines for cancer therapy.
    Tang M; Ren X; Fu C; Ding M; Meng X
    J Mater Chem B; 2021 Jul; 9(29):5749-5764. PubMed ID: 34196332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanoscale drug delivery for targeted chemotherapy.
    Xin Y; Huang Q; Tang JQ; Hou XY; Zhang P; Zhang LZ; Jiang G
    Cancer Lett; 2016 Aug; 379(1):24-31. PubMed ID: 27235607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advanced nanomedicines for the regulation of cancer metabolism.
    Yang J; Zhao Y; Zhou Y; Wei X; Wang H; Si N; Yang J; Zhao Q; Bian B; Zhao H
    Biomaterials; 2022 Jul; 286():121565. PubMed ID: 35576808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bridging Bio-Nano Science and Cancer Nanomedicine.
    Björnmalm M; Thurecht KJ; Michael M; Scott AM; Caruso F
    ACS Nano; 2017 Oct; 11(10):9594-9613. PubMed ID: 28926225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Prominent Role of Protein-Based Delivery Systems on the Development of Cancer Treatment.
    Kouchakzadeh H; Abbas Shojaosadati S
    Curr Pharm Des; 2016; 22(22):3455-65. PubMed ID: 26845324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.